Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a Cardiac Safety Research Consortium / Health and Environmental Sciences Institute / FDA Meeting

Therapeutic Innovation & Regulatory Science
David StraussPhilip Sager

Abstract

A Cardiac Safety Research Consortium / Health and Environmental Sciences Institute / FDA-sponsored Think Tank Meeting was convened in Washington, DC, on May 21, 2018, to bring together scientists, clinicians, and regulators from multiple geographic regions to evaluate progress to date in the Comprehensive In Vitro Proarrhythmia Assay (CiPA) Initiative, a new paradigm to evaluate proarrhythmic risk. Study reports from the 4 different components of the CiPA paradigm (ionic current studies, in silico modeling to generate a Torsade Metric Score, human induced pluripotent stem cell-derived ventricular cardiomyocytes, and clinical ECG assessments including J-Tpeakc) were presented and discussed. This paper provides a high-level summary of the CiPA data presented at the meeting.

References

Dec 18, 2013·Clinical Pharmacology and Therapeutics·L JohannesenD G Strauss
Jul 15, 2015·Journal of Biomolecular Screening·Bernard FerminiJamie I Vandenberg
Aug 12, 2015·Clinical Pharmacology and Therapeutics·L JohannesenD G Strauss
Oct 5, 2016·Toxicological Sciences : an Official Journal of the Society of Toxicology·Ksenia BlinovaDavid G Strauss
Dec 14, 2016·Journal of Pharmacological and Toxicological Methods·Hiroyuki AndoYuko Sekino
Sep 8, 2017·Frontiers in Physiology·Sara DuttaZhihua Li

❮ Previous
Next ❯

Citations

Feb 25, 2020·Clinical Pharmacology and Therapeutics·Ken WangBenjamin Ribba
Jul 13, 2019·Frontiers in Physiology·Pras PathmanathanRichard A Gray
Jun 18, 2020·APL Bioengineering·Minki HwangEun Bo Shim
Aug 14, 2019·Frontiers in Physiology·Katerina HnatkovaMarek Malik
Feb 18, 2020·Natural Product Reports·Saumya BajajK George Chandy
Oct 17, 2019·American Journal of Physiology. Cell Physiology·Nathan Robert ScrimgeourMorten Andre Høydal
Oct 23, 2019·Scientific Reports·Katerina HnatkovaMarek Malik
Dec 2, 2020·International Journal of Molecular Sciences·Junjun LiYoshiki Sawa
Jul 7, 2020·Journal of Pharmacological and Toxicological Methods·Matthias GoßmannSonja Stoelzle-Feix
Mar 25, 2020·Toxicology Research·Kimberly L RockleyMichael J Morton
Aug 22, 2020·Regulatory Toxicology and Pharmacology : RTP·Gary GintantKsenia Blinova
Nov 26, 2019·Toxicological Sciences : an Official Journal of the Society of Toxicology·Andre Monteiro da RochaTodd J Herron
Dec 17, 2020·Journal of Cardiovascular Pharmacology·Michelangelo PaciJussi T Koivumäki
Mar 18, 2021·Cardiovascular Research·Valentina PaloschiLars Maegdefessel
May 8, 2021·Journal of Pharmacological and Toxicological Methods·Damian C Bell, Bernard Fermini
Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Magdalena KowalskaAlicja Nowaczyk
Aug 18, 2021·Journal of Pharmacological and Toxicological Methods·Damian C Bell, Bernard Fermini
Aug 24, 2021·Journal of Chemical Information and Modeling·Kuo Hao LeeLei Shi
Nov 27, 2021·Physiological Reports·Mohamadamin ForouzandehmehrMichelangelo Paci
Jan 2, 2022·Archives of Toxicology·Atsushi MasuiShimpei Gotoh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.